Divalent Metal Ion Complexes of S100B in the Absence And Presence 5 of Pentamidine
As part of an effort to inhibit S100B, structures of pentamidine (Pnt) bound to Ca{sup 2+}-loaded and Zn{sup 2+},Ca{sup 2+}-loaded S100B were determined by X-ray crystallography at 2.15 {angstrom} (R{sub free} = 0.266) and 1.85 {angstrom} (R{sub free} = 0.243) resolution, respectively. These data were compared to X-ray structures solved in the absence of Pnt, including Ca{sup 2+}-loaded S100B and Zn{sup 2+},Ca{sup 2+}-loaded S100B determined here (1.88 {angstrom}; R{sub free} = 0.267). In the presence and absence of Zn{sup 2+}, electron density corresponding to two Pnt molecules per S100B subunit was mapped for both drug-bound structures. One Pnt binding site (site 1) was adjacent to a p53 peptide binding site on S100B ({+-} Zn{sup 2+}), and the second Pnt molecule was mapped to the dimer interface (site 2; {+-} Zn{sup 2+}) and in a pocket near residues that define the Zn{sup 2+} binding site on S100B. In addition, a conformational change in S100B was observed upon the addition of Zn{sup 2+} to Ca{sup 2+}-S100B, which changed the conformation and orientation of Pnt bound to sites 1 and 2 of Pnt-Zn{sup 2+},Ca{sup 2+}-S100B when compared to Pnt-Ca{sup 2+}-S100B. That Pnt can adapt to this Zn{sup 2+}-dependent conformational change was unexpected and provides a new mode for S100B inhibition by this drug. These data will be useful for developing novel inhibitors of both Ca{sup 2+}- and Ca{sup 2+},Zn{sup 2+}-bound S100B.
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 958597
- Report Number(s):
- SLAC-REPRINT-2009-092; JMOBAK; TRN: US201001%%639
- Journal Information:
- J. Mol. Biol. 382:56,2008, Vol. 382, Issue 1; ISSN 0022-2836
- Country of Publication:
- United States
- Language:
- English
Similar Records
Pentamidine blocks the interaction between mutant S100A5 and RAGE V domain and inhibits the RAGE signaling pathway
Purification, crystallization and preliminary X-ray diffraction studies on human Ca{sup 2+}-binding protein S100B